FOR IMMEDIATE RELEASE- (Washington D.C. – April 24, 2024) On April 1, 2024 Community Voices for 340B submitted a response to Senators Thune, Stabenow, Capito, Baldwin, Moran, and Cardin’s second request for information on the 340B Drug Discount Program. In it’s response CV340B conducted independent analysis of the publicly available HRSA audit reports finding that…
Details
In a recent guest opinion essay published in the New York Times, Dr. Lindsay Ryan, University of California, argues that end-stage poverty is killing Americans. Dr. Ryan is an associate physician at the University of California, San Francisco, Department of Medicine. It is a safety-net hospital, which Dr. Ryan describes as “institutions that disproportionately serve…
Details
PRESS RELEASE – April 23, 2024 Damien Center, Indiana’s oldest and largest AIDS service organization, has partnered with CV340B to educate the Indiana community about the federal 340B program and its importance through CV340B’s Digital Engagement Campaign, Together with 340B. Launched earlier this month, the ads speak to the potential future impact on American Taxpayers…
Details
In a recent decision, the US District Court of Appeals Upheld State’s Rights to Regulate 340B.Some key quotes from the ruling. First, the 340B Program is not “so pervasive . . . that Congress left no room for the States to supplement it.” Pharmacies have always been an essential part of the 340B Program. Yet,…
Details
Black Pharmacists Advocate for 340B For over 30 years, the federal 340B Drug Pricing program (340B) has enabled covered entities to be the healthcare safety-net for vulnerable Americans. The Los Angeles Sentinel recently published an article by three black pharmacists, Dr. Kenneth Schell, Dr. John Clark, and Dr. Anthony Jackson. In the article, they…
Details
In a recent decision, the US District Court of South Carolina reinforces the original intention of patient definition for 340B covered entities, advocating for a ‘broad’ interpretation. Emphasizing the program’s core mission, the ruling reinforces Congress’ initial intent—to safeguard vulnerable communities from skyrocketing drug costs. This reaffirmation solidifies the program’s commitment to ensuring vital access…
Details
A New Groundbreaking Study Reveals Real-Life Impact, Cost Savings, and Barriers Faced by Underserved Diabetes Patients in Safety-Net Clinics The federal 340B Drug Pricing Program provides discounted drug prices to safety-net entities, enabling them to serve more vulnerable patients. This program has become indispensable with the escalating costs of medications, including high-cost injectable diabetes…
Details
Five Horizons Health Services Provides HIV Prevention in West Alabama & East Mississippi with 340B The 340B Program allows the rural healthcare facility to provide high-quality, patient-centered medical, dental, prevention, behavioral health, testing, and case management services. by Shey Thorn, MPH, Chief of Staff, Five Horizons Health Services October 2023 Five Horizons Health Services…
Details
History of the 340B Program by Januari Fox, Director of Policy & Advocacy, Community Engagement, Prism Health North Texas Administration October 2022 Republished from the Dallas Medical Journal. Find the original article here. A little-known program that establishes pathways of care for underserved communities is under attack by drug manufacturers. Created in 1992, the…
Details
Rural Hospitals Rely on the 340B Drug Pricing Program by Craig Thompson, Missouri Independent September 12, 2023 Republished from the Missouri Independent. Find original article HERE. According to a recent report, roughly 35% of rural hospitals in Missouri are at risk of closing as a result of inadequate revenue and low financial reserves. This comes as…
Details